Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
5,036
Funds Holding Change
+244
Funds Holding Growth
+5%
Value
$1.55T
Holding in Top 10
1,622
Top 10 Change
+122
Top 10 Growth
+8%
Value Growth
+14%
New
447
Increased
2,163
Reduced
2,098
Closed
87
Capital Inflow
$48.9B
Capital Outflow
$31.9B
Net Capital Flow
+$17B
Capital Flow Change
+$20.4B
Calls
$21.7B
Puts
$19.7B
Net Calls
+$2B
Put/Call Ratio
0.91